Home - Commentary
17 October 2012
Over the past 18 months the market has witnessed a series of transactions involving the sale of pharmaceutical consulting firms. Recent deal activity includes the acquisitions of Bridgehead International, Double Helix Development, and the Drug Safety Alliance with buyers spanning other consulting ...
16 August 2012
From clinician notes to insurance claims and laboratory test results to adverse event reports, health care systems are awash with data and data volumes are growing rapidly. According to a recent Oracle survey, U.S. and Canadian healthcare organisation are accumulating 85% more data than two years ...
30 May 2012
From study recruitment, through to patient testing and specimen collection, the desire for increased patient centricity in clinical trials is shaking up the clinical trial supply chain. The potential for a sea change in how and where clinical trials are conducted is presenting opportunities for new ...
04 April 2012
Companies that provide technology-enabled solutions that improve the quality and efficiency of clinical trials could soon find themselves attractive partners or acquisition targets for new entrants to the healthcare space. The potential to leverage clinical trial technologies such as ePRO to ...
23 February 2012
Research sites behave as though they ‘own’ patients, but of course they don’t, they are only gate keepers. Patients are fully in charge of their own medical care and are the final arbiters of whether they would like to participate in a clinical trial or not. It would make sense then, to assume that ...
09 February 2012
There has been increased interest across the life sciences industry to use lower-cost regions such as India, China, Eastern Europe, South America and South Africa to support functions including data management, programming, statistics, pharmacovigilance and medical writing across drug development ...
Expecting data for this section.
© 2016 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36

In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer.

By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way Scrip Clinical Research uses cookies please go to our Cookie Policy page.